Jiangsu Hengrui Pharmaceuticals Co., Ltd.
CIK 2080343 · View on SEC EDGAR ↗
Insider
First SEC filing: April 16, 2026 · Latest: April 16, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 6 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | BRVE | C | 7,420,091 | — | — | 7,420,091 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 7, 2026 | BRVE | C | 32,500,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2026 | KLRA | C | 708,814 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2026 | KLRA | C | 4,968,789 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2026 | KLRA | C | 2,034,133 | — | — | 2,034,133 Direct | — | Acquired | (price as of 2026-08-21) |
| April 20, 2026 | KLRA | C | 9,477,719 | — | — | 9,477,719 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | BRVE | Non-voting Series A preferred stock | Common Stock (7,420,091) | — | — | 32,500,000 | Disposed |
| April 20, 2026 | KLRA | Series A-2 convertible non-voting preferred stock | Common Stock (2,034,133) | — | — | 708,814 | Disposed |
| April 20, 2026 | KLRA | Series A-2 convertible preferred stock | Common Stock (9,477,719) | — | — | 4,968,789 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 6, 2026 | BRVE | Non-voting Series A preferred stock→ Common Stock (7,420,091) | 7,420,091 | Direct |
| April 16, 2026 | KLRA | Common Stock | 1 | Indirect |
| April 16, 2026 | KLRA | Series A-2 convertible preferred stock→ Common Stock (9,477,719) | 9,477,719 | Direct |
| April 16, 2026 | KLRA | Series A-2 convertible non-voting preferred stock→ Common Stock (2,034,133) | 2,034,133 | Direct |